title: Preoperative arterial embolization of large liver hemangiomas.
abstract: OBJECTIVE
  We aimed to investigate the efficacy and safety of preoperative selective intra-arterial embolization (PSIAE) in the surgical treatment of large liver hemangiomas.
  
  
  METHODS
  Data of 22 patients who underwent resection of large liver hemangiomas were retrospectively analyzed. PSIAE was performed in cases having a high risk of severe blood loss during surgery (n=11), while it was not applied in cases with a low risk of blood loss (n=11).
  
  
  RESULTS
  A total of 19 enucleations and six anatomic resections were performed. Operative time, intraoperative bleeding amount, Pringle period, and blood transfusion were comparable between the two groups (P > 0.05, for all). The perioperative serum aspartate transaminase level was not different between groups (P = 1.000). Perioperative total bilirubin levels were significantly increased in the PSIAE group (P = 0.041). Postoperative hospital stay was longer in the PSIAE group. Surgical complications were comparable between groups (P = 0.476).
  
  
  CONCLUSIONS
  Patients who underwent PSIAE due to a high risk of severe blood loss during resection of large liver hemangiomas had comparable operative success as patients with a low risk of blood loss who were operated without PSIAE. Hence, PSIAE can be used for the control of intraoperative blood loss, especially in surgically difficult cases.
authors: Department of Surgery, Karadeniz Technical University, School of Medicine, Farabi Hospital, Trabzon, Turkey. serdartopaloglu@yahoo.com.
authors: Serdar
authors: S
authors: Topaloğlu
authors: Şükrü
authors: Ş
authors: Oğuz
authors: Orhan
authors: O
authors: Kalaycı
authors: M Halil
authors: MH
authors: Öztürk
authors: Adnan
authors: A
authors: Çalık
authors: Hasan
authors: H
authors: Dinç
authors: Ümit
authors: Ü
authors: Çobanoğlu
mesh_terms: D000328:Adult; D016063:Blood Loss, Surgical / Q000517:prevention & control; D004621:Embolization, Therapeutic / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006391:Hemangioma / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006498:Hepatectomy / Q000009:adverse effects / Q000379:methods; D006801:Humans; D007902:Length of Stay; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology; D011300:Preoperative Care / Q000379:methods; D011859:Radiography; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D006495:Heparin, Low-Molecular-Weight